Chemoattraction of human blood T lymphocytes by interleukin-15 - PubMed (original) (raw)

Chemoattraction of human blood T lymphocytes by interleukin-15

P C Wilkinson et al. J Exp Med. 1995.

Abstract

Recombinant interleukin (IL)-15, derived from a simian kidney epithelial cell line, is a chemoattractant for human blood T lymphocytes judged by its ability to increase the proportion of cells in polarized morphology, to stimulate invasion of collagen gels containing IL-15, and to increase the proportion of locomotor cells observed by time-lapse videorecording. The ability of lymphocytes to respond was partly, but not completely, inhibited by pretreatment with anti-IL-2 receptor beta-chain. The activity of IL-15 was completely abolished by preincubation with aIL-15 but unaffected by preincubation with aIL-2. No response of monocytes, neutrophils, or B lymphocytes to IL-15 was observed.

PubMed Disclaimer

Similar articles

• Recombinant IL-4 and IFN-gamma activate locomotor capacity in human B lymphocytes.
  Wilkinson PC, Islam LN. Wilkinson PC, et al. Immunology. 1989 Jun;67(2):237-43. Immunology. 1989. PMID: 2502496 Free PMC article.
• B cell stimulating factor 2/interleukin 6 is a costimulant for human thymocytes and T lymphocytes.
  Lotz M, Jirik F, Kabouridis P, Tsoukas C, Hirano T, Kishimoto T, Carson DA. Lotz M, et al. J Exp Med. 1988 Mar 1;167(3):1253-8. doi: 10.1084/jem.167.3.1253. J Exp Med. 1988. PMID: 3127525 Free PMC article.
• Functional activation of human neutrophils by recombinant monocyte-derived neutrophil chemotactic factor/IL-8.
  Djeu JY, Matsushima K, Oppenheim JJ, Shiotsuki K, Blanchard DK. Djeu JY, et al. J Immunol. 1990 Mar 15;144(6):2205-10. J Immunol. 1990. PMID: 2155963
• Recombinant interleukin 4 and partially purified low-molecular-weight B-cell growth factor stimulate normal resting human T lymphocytes.
  Martinez O, Gibbons R, Marra M, Garovoy MR. Martinez O, et al. Transplant Proc. 1989 Feb;21(1 Pt 1):74-6. Transplant Proc. 1989. PMID: 2784902 No abstract available.
• Mediators and modulators of human lymphocyte chemotaxis.
  van Epps DE. van Epps DE. Agents Actions Suppl. 1983;12:217-33. doi: 10.1007/978-3-0348-9352-7_13. Agents Actions Suppl. 1983. PMID: 6220584 Review. No abstract available.

Cited by

• IL-15 and IL-15R alpha gene deletion: effects on T lymphocyte trafficking and the microglial and neuronal responses to facial nerve axotomy.
  Huang Z, Ha GK, Petitto JM. Huang Z, et al. Neurosci Lett. 2007 May 1;417(2):160-4. doi: 10.1016/j.neulet.2007.01.086. Epub 2007 Mar 25. Neurosci Lett. 2007. PMID: 17418948 Free PMC article.
• Cytokine profile during latent and slowly progressive primary tuberculosis: a possible role for interleukin-15 in mediating clinical disease.
  Abebe F, Mustafa T, Nerland AH, Bjune GA. Abebe F, et al. Clin Exp Immunol. 2006 Jan;143(1):180-92. doi: 10.1111/j.1365-2249.2005.02976.x. Clin Exp Immunol. 2006. PMID: 16367949 Free PMC article.
• Heterogeneous interleukin-15 inducibilities in murine B16 melanoma and RM-1 prostate carcinoma by interferon-alpha treatment.
  Wu TG, Perdigão JR, Umhoefer TK, Cao J, Ansari DA, Albrecht TB, Knutson EP, Rose WA 2nd, Jorgensen AJ, Ryan LM, Abdalla LE, Fleischmann WR Jr. Wu TG, et al. J Interferon Cytokine Res. 2009 Nov;29(11):719-28. doi: 10.1089/jir.2008.0073. J Interferon Cytokine Res. 2009. PMID: 19642895 Free PMC article.
• Loss of CNS IL-2 gene expression modifies brain T lymphocyte trafficking: response of normal versus autoreactive Treg-deficient T cells.
  Huang Z, Meola D, Petitto JM. Huang Z, et al. Neurosci Lett. 2011 Jul 25;499(3):213-8. doi: 10.1016/j.neulet.2011.05.230. Epub 2011 Jun 6. Neurosci Lett. 2011. PMID: 21669253 Free PMC article.
• Elimination of oncogenic KRAS in genetic mouse models eradicates pancreatic cancer by inducing FAS-dependent apoptosis by CD8+ T cells.
  Mahadevan KK, LeBleu VS, Ramirez EV, Chen Y, Li B, Sockwell AM, Gagea M, Sugimoto H, Sthanam LK, Tampe D, Zeisberg M, Ying H, Jain AK, DePinho RA, Maitra A, McAndrews KM, Kalluri R. Mahadevan KK, et al. Dev Cell. 2023 Sep 11;58(17):1562-1577.e8. doi: 10.1016/j.devcel.2023.07.025. Epub 2023 Aug 24. Dev Cell. 2023. PMID: 37625403 Free PMC article.

References

1. 1. J Cell Biol. 1972 Sep;54(3):626-37 - PubMed
2. 1. Immunology. 1994 May;82(1):134-9 - PubMed
3. 1. J Immunol. 1978 Apr;120(4):1372-4 - PubMed
4. 1. Clin Exp Immunol. 1985 Mar;59(3):520-8 - PubMed
5. 1. J Immunol. 1985 Jun;134(6):3887-90 - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Europe PubMed Central
  • Ovid Technologies, Inc.
  • PubMed Central
  • Silverchair Information Systems

• Other Literature Sources

  • The Lens - Patent Citations Database